Author

Zoi Mastora

Institut d'Investigació Biomédica de Bellvitge

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 2 Approach:experimental assay· 2 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Antonio GentilellaiD· 2 shared Berta Forcada· 2 shared Cristina SantosiD· 2 shared Francisco D. Morón-DuraniD· 2 shared Pau Bosch-i-CrespoiD· 2 shared Ramón SalazariD· 2 shared Albert TauleriD· 1 shared Brandon E. Frank· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Antonio GentilellaORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Pharmacologic decoupling of IRBC activation from anabolic collapse redefines ribosome biogenesis inhibition as a selective tumor suppressive strategy

Sandra Menoyo, Berta Forcada, Zoi Mastora, Pau Bosch-i-Crespo, Francisco D. Morón-Duran, Cristina Santos, Ramón Salazar, Antonio Gentilella

This study shows that inhibiting ribosome biogenesis can selectively activate the IRBC checkpoint in TP53-proficient cells, offering a new therapeutic strategy for cancer.

bioRxiv · Aug 27, 2026 · PreprintCancer Biology

LARP1 integrates MYC and mTOR signaling to enable anabolic growth during tumor initiation

Pedro Fuentes, Flavia Iannizzotto, Elisa Battaglia, Chiara Balzamo, Carla Tola, Berta Forcada, Pau Bosch-i-Crespo, Francisco D. Morón-Duran, Brandon E. Frank, Carolina Martinez- Herraez, Zoi Mastora, Gabriella Manfili-Marinho, Albert Tauler, Cristina Santos, Ramón Salazar, Antonio Gentilella

This study identifies LARP1 as a critical effector linking MYC and mTOR signaling in tumor initiation, showing its role in translating MYC-driven anabolic programs under metabolic permissiveness.

Proceedings of the National Academy of Sciences · Jun 12, 2026Peer-reviewedCancer Biology